CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

ASTRAZENECA PHARMACEUTICALS recalls Fasenra (benralizumab) Injection

Read the official FDA notice

Published
22 Oct 2025
Units affected
916 pre-filled syringes
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility:

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

Brand / company
ASTRAZENECA PHARMACEUTICALS
Codes / lots
Lot YJ0152, Expiry: 01/31/2028.
Distribution
Nationwide in the U.S
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.